NCT00002153已完成1 期
Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 25
- 试验地点
- 2
研究概览
简要总结
To evaluate topical A-007 in patients with advanced malignancies including Kaposi's sarcoma and lymphoproliferative disorders.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
1 期
Doxycycline in Cutaneous Schwannoma (NF2)Neurofibromatosis Type 2NCT05521048Massachusetts Eye and Ear Infirmary19
已完成
2 期
A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa NigraDermatosis Papulosa NigraNCT03224598Aclaris Therapeutics, Inc.39
已完成
不适用
Efficacy study of topical formulations (BH07, BH08)Healthy adultsJPRN-UMIN000037856Kao Corporation48
招募中
2 期
Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized PatientsErectile Dysfunction Following Radical ProstatectomyRadical ProstatectomyProstate CancerErectile DysfunctionNCT05558007Biozeus Biopharmaceutical S.A.72
进行中（未招募）
3 期
A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated PatientsRecessive Dystrophic Epidermolysis BullosaRDEBEpidermolysis BullosaNCT05725018Abeona Therapeutics, Inc12